162 related articles for article (PubMed ID: 27534375)
1. Hyperbaric oxygen treatment suppresses withdrawal signs in morphine-dependent mice.
Nicoara D; Zhang Y; Nelson JT; Brewer AL; Maharaj P; DeWald SN; Shirachi DY; Quock RM
Brain Res; 2016 Oct; 1648(Pt A):434-437. PubMed ID: 27534375
[TBL] [Abstract][Full Text] [Related]
2. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
3. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
4. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
5. The differential profiles of withdrawal symptoms induced by morphine and beta-endorphin administered intracerebroventricularly in mice.
Park SH; Sim YB; Kang YJ; Kim CH; Kwon MS; Suh HW
Neuroscience; 2012 Aug; 218():216-25. PubMed ID: 22626645
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide trefoil factor 3 attenuates naloxone-precipitated withdrawal in morphine-dependent mice.
Wu P; Shi HS; Luo YX; Zhang RX; Li JL; Shi J; Lu L; Zhu WL
Psychopharmacology (Berl); 2014 Dec; 231(24):4659-68. PubMed ID: 24825609
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
Pinelli A; Trivulzio S
J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
Singh P; Sharma B; Gupta S; Sharma BM
Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
[TBL] [Abstract][Full Text] [Related]
9. Ethological analysis of morphine withdrawal with different dependence programs in male mice.
Broseta I; RodrÃguez-Arias M; Stinus L; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):335-47. PubMed ID: 11817512
[TBL] [Abstract][Full Text] [Related]
10. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
11. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
[TBL] [Abstract][Full Text] [Related]
12. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
[TBL] [Abstract][Full Text] [Related]
13. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats.
Ghaemi-Jandabi M; Azizi H; Ahmadi-Soleimani SM; Semnanian S
Brain Res Bull; 2017 Apr; 130():107-111. PubMed ID: 28093335
[TBL] [Abstract][Full Text] [Related]
14. Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Ohsawa M; Kamei J
Brain Res; 1999 Jan; 815(2):424-30. PubMed ID: 9878862
[TBL] [Abstract][Full Text] [Related]
15. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
[TBL] [Abstract][Full Text] [Related]
16. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats.
Rawls SM; Baron DA; Kim J
Behav Pharmacol; 2010 Mar; 21(2):161-4. PubMed ID: 20215965
[TBL] [Abstract][Full Text] [Related]
17. [The potential antinarcotic effects of guanfacine].
Marusov IV; Bogdanov EG; Marusova IB
Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
[TBL] [Abstract][Full Text] [Related]
18. Quantitative opioid withdrawal signs in rats: effects exerted by clothiapine administration.
Pinelli A; Trivulzio S; Ciapponi PM
Fundam Clin Pharmacol; 1997; 11(4):346-55. PubMed ID: 9263765
[TBL] [Abstract][Full Text] [Related]
19. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
[TBL] [Abstract][Full Text] [Related]
20. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
